Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan and Amlodipine Combination in Hypertension
NCT02651870Phase 3Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Apr 2015
- Primary completion
- Feb 2016
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of candesartan, amlodipine in hypertension (HTN), sponsored by Chong Kun Dang Holdings. Started Apr 2015; status: completed.
02
Drugs
candesartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02651870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02651870.